Actinogen Medical Limited (ACW.AX)

0,0290 -0,0010 (-3,33%) Ab 01:51PM AEST. Markt geöffnet.

Actinogen Medical Limited

109 Pitt Street
Suite 901 Level 9
Sydney, NSW 2000
Australia
61 2 8964 7401
https://www.actinogen.com.au

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.	MD, CEO & Director	514,44k	N/A	1960
Dr. Dana C. Hilt M.D.	Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board	385,4k	N/A	1953
Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.	Head of Clinical Pharmacology & Lead Physician and Depression	94,63k	N/A	N/A
Mr. William Edward Souter BCom, IPAA, LLB (Adel)	Chief Financial Officer	N/A	N/A	N/A
Mr. Michael Roberts	Head of Investor Relations & Corporate Communications	N/A	N/A	N/A
Dr. Fujun Li Ph.D.	Head of Manufacturing	N/A	N/A	N/A
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.	Company Secretary	N/A	N/A	1963

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Corporate Governance

Actinogen Medical Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.